Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
about
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.Major milestones in translational oncology.Risk Factors and Preventions of Breast Cancer.The diagnostic role of PTEN and ARID1A in serous effusions.Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field
P2860
Q38661390-4EAFF122-173B-4477-B737-BE6F9582472BQ39767744-C279107A-630D-4C18-A89F-ABEAB5115F79Q41149668-A6304ACF-F277-498C-A55E-648D016C2501Q42398020-D0DD7E90-22D0-4D3A-A816-DA4B3AD9DE10Q47100005-074146A7-CE56-4EBB-8990-D4839FC06FDAQ47369086-7AF3CB65-4C4F-4EAF-8289-C153A27BEE8FQ47782850-FFC484C8-90D0-4185-BA6D-562F2DD2F722Q48354684-976537FD-BA9A-475B-9756-BDA83D12E276Q55428234-F98CA86C-5049-4D03-A3C0-D7DBB3A98278Q57495764-5F51FBEF-B5AA-4700-A44B-B1BEC250B877
P2860
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@en
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@nl
type
label
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@en
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@nl
prefLabel
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@en
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@nl
P2093
P50
P1476
Integrated Analysis of PTEN an ...... n HER2-Positive Breast Cancer.
@en
P2093
Alexander Klimowicz
Arndt Hartmann
Berit Pfitzner
Bianca Lederer
Christian Jackisch
Gunter von Minckwitz
Holger Eidtmann
Jenny Furlanetto
Jens Huober
Katharina Tiemann
P304
P356
10.1158/1078-0432.CCR-15-0965
P407
P577
2016-01-12T00:00:00Z